Bing-Fei Xu
Bing-Fei Xu publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Molecular Biology, on topics such as Lung Cancer Treatments and Mutations, Lung Cancer Research Studies and Cancer Immunotherapy and Biomarkers.
- World rank
- #2,191,239 of 7,710,434 ranked researchers
- Rank in China
- #339,777 of 978,568
- Works
- 17
- Citations
- 1.1k
- Citations per work
- 62.1
What does Bing-Fei Xu research?
Bing-Fei Xu's work is mostly in Medicine (79%), Biochemistry, Genetics and Molecular Biology (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1379.3%
- Medicine1379.3%
- Everything else212.4%
- Life Sciences18.3%
- 1Oncology40% of their works
- 2Pulmonary and Respiratory Medicine31% of their works
- 3Molecular Biology8% of their works
- 4Radiology, Nuclear Medicine and Imaging4% of their works
- 5Epidemiology2% of their works
- 6Surgery2% of their works
Research topics
Which keywords describe Bing-Fei Xu's research?
The keywords of their largest research topics: Targeted Therapy, Clinical Trials, Chemotherapy, ALK Inhibitors, EGFR Mutations, Immunotherapy, Genomic Profiles and Small-Cell Lung Cancer.
- mTOR
- Mutational Signatures
- Radiosurgery
- CT Screening
- HER2
- PD-1 and PD-L1
- Small-Cell Lung Cancer
- Immunotherapy
- ALK Inhibitors
- Clinical Trials
- Targeted Therapy
- Chemotherapy
- EGFR Mutations
- Genomic Profiles
- Immune Checkpoint Blockade
- Breast Cancer
- Brain Metastases
- Lung Cancer
- Cancer Genomics
- Signaling
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Targeted Therapy163 topics
- Clinical Trials152 topics
- Chemotherapy113 topics
- ALK Inhibitors91 topic
- EGFR Mutations91 topic
- Immunotherapy82 topics
- Genomic Profiles61 topic
- Small-Cell Lung Cancer61 topic
- Immune Checkpoint Blockade41 topic
- PD-1 and PD-L141 topic
- Breast Cancer31 topic
- HER231 topic
- Brain Metastases21 topic
- CT Screening21 topic
- Lung Cancer21 topic
- Radiosurgery21 topic
- Cancer Genomics11 topic
- Mutational Signatures11 topic
- Signaling11 topic
- mTOR11 topic
Where does Bing-Fei Xu work?
Bing-Fei Xu's main affiliation in the publication record is Guangdong Academy of Medical Sciences, China.
How many publications and citations does Bing-Fei Xu have?
OpenAlex counts 17 works and 1,055 citations for Bing-Fei Xu, an h-index of 8, ranking #2,191,239 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Bing-Fei Xu. Posts are plain text and can be reported.